Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : New Brunswick Scientific Co., Inc. (NBSC) -- Ignore unavailable to you. Want to Upgrade?

To: David Richardson who wrote (54)	6/28/2000 7:44:00 PM
From: scaram(o)uche	Respond to of 724

Yeah, but we know, Dave, that you go back, with biotech investing, to at least the days of misc.invest.stocks. We therefore know that you must be looney too. <g> (thanks) barely on topic..... Mallinckrodt gets gobbled. They're the partner of Palatin, going in front of advisory committee in next couple of weeks. Prendergast, coauthor of the latest DGI-related GEN article with Blume, is Interim Chairman of the Board at Palatin........ Wednesday June 28, 7:26 pm Eastern Time Tyco To Buy Mallinckrodt for $4.2B ST. LOUIS (AP) -- Tyco International Ltd. will buy Mallinckrodt Inc. (NYSE:MKG - news) of St. Louis for about $4.2 billion in stock, both companies announced Wednesday. Tyco, based in Exeter, N.H., manufactures electrical and electronic components, flow control valves and medical devices. Mallinckrodt Inc. is a global healthcare company. In the acquisition, Mallinckrodt shareholders will receive Tyco shares valued at $47.50 for each share of Mallinckrodt. Mallinckrodt, which had 1999 revenues of $2.6 billion, has major positions in respiratory care, diagnostic imaging and analgesic pharmaceuticals. ``Mallinckrodt provides an excellent strategic fit with Tyco Healthcare, with complementary products, services and geographic reach, as well as platforms for future growth,'' said L. Dennis Kozlowski, Tyco chairman and CEO. Tyco officials say they are hoping the acquisition will help Tyco Healthcare expand in respiratory care arena. ``This transaction provides exceptional value for our shareholders and allows Mallinckrodt shareholders to participate in the future growth of Tyco,'' said C. Ray Holman, Mallinckrodt chairman and CEO. Tyco is the world's largest manufacturer, installer and provider of fire protection systems and electronic security services. Mallinckrodt is the number one manufacturer of bulk narcotics and other drug chemicals, and is the world's largest producer of pain reliever acetaminophen. The company also provides laboratory and microelectronic chemicals. Shares of Mallinckrodt were up 10 percent, or $2.875, at $31.625 on the New York Stock Exchange, where shares of Tyco were down nearly 5 percent, or $2.313, at $45.